首页> 外文会议>SIGBioMed workshop on biomedical natural language processing;Annual meeting of the Association for Computational Linguistics >Improving classification of Adverse Drug Reactions through Using Sentiment Analysis and Transfer Learning
【24h】

Improving classification of Adverse Drug Reactions through Using Sentiment Analysis and Transfer Learning

机译:通过情感分析和转移学习改善药物不良反应的分类

获取原文

摘要

The availability of large-scale and real-time data on social media has motivated research into adverse drug reactions (ADRs). ADR classification helps to identify negative effects of drags, which can guide health professionals and pharmaceutical companies in making medications safer and advocating patients' safety. Based on the observation that in social media, negative sentiment is frequently expressed towards ADRs, this study presents a neural model that combines sentiment analysis with transfer learning techniques to improve ADR detection in social media postings. Our system is firstly trained to classify sentiment in tweets concerning current affairs, using the SemEval17-task4A corpus. We then apply transfer learning to adapt the model to the task of detecting ADRs in social media postings. We show that, in combination with rich representations of words and their contexts, transfer learning is beneficial, especially given the large degree of vocabulary overlap between the current affairs posts in the SemEval17-task4A corpus and posts about ADRs. We compare our results with previous approaches, and show that our model can outperform them by up to 3% F-score.
机译:社交媒体上大规模和实时数据的可用性激发了人们对药物不良反应(ADR)的研究。 ADR分类有助于识别药物的负面影响,这可以指导卫生专业人员和制药公司提高药物的安全性并倡导患者的安全。基于在社交媒体中经常对ADR表示负面情绪的观察,本研究提出了一种将情感分析与转移学习技术相结合的神经模型,以改善社交媒体发布中的ADR检测。我们的系统首先经过训练,可使用SemEval17-task4A语料对有关时事的推文中的情感进行分类。然后,我们应用转移学习使模型适应社交媒体发布中检测ADR的任务。我们表明,结合单词及其上下文的丰富表示形式,转移学习是有益的,特别是考虑到SemEval17-task4A语料库中的时事帖子与ADR帖子之间的词汇重叠程度很高。我们将我们的结果与以前的方法进行了比较,并表明我们的模型可以将其性能提高3%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号